Novartis Corporation - Bathi saben saham sajrone 12 wulan pungkasan NVS

Logo perusahaan publik Novartis Inc. (NVS)

Novartis AG (NVS) earns revenue through a diverse portfolio of drugs and fundamental healthcare needs. The strategic exit from the generics segment solidified the company's dominance in high-margin, high-tech therapy. An environmental focus and trial ethics are complemented by the annual change in net income per share over a rolling period, where the -28.70 metric determines the status of the business profitability parameter.

NVS Novartis Corporation: Bathi saben saham sajrone rolas wulan pungkasan ing interval 11.02.2024 - 17.11.2026

NVS (Novartis): rincian analitis lan laporan miturut indikator

- rega saham lan prakiraan rega para ahli:
Analisis wiwitan perusahaan:NVS, Novartis Inc.
Produk mawa merek novartis.com

Year-over-year EPS growth (TTM) measures the rolling growth rate of net income per share, smoothing out gaps between quarterly reports. The 12-month EPS growth trend, with a current value of -28.70, determines the vector of the asset's fundamental reliability. This model is sensitive to peak values, which may signal that the stock is overbought. For Novartis AG (NVS), the Swiss jurisdiction and its status as a manufacturer of critical drugs minimize geopolitical risks, stabilizing this metric.